GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

The papillary tumors seemed to be arising from ... Pathologic analysis demonstrated Gleason grade 4 + 5 ductal carcinoma of the prostate. Histologic examination showed large, pleomorphic cells ...

Sacituzumab govitecan is under clinical development by Gilead Sciences and currently in Phase II for Papillary Thyroid Cancer.

This latest approval for Orpathys in NSCLC makes the drug available in both the first- and second-line settings.

partners.org Objective Invasive cancers arising from intraductal papillary mucinous neoplasm (IPMN ... and 570 patients with pancreatic ductal adenocarcinoma (PDAC, control group) resected at a single ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

说到体检报告上哪两个字最触动人心，“结节”一定榜上有名，肺结节、甲状腺结节、乳腺结节.....身边总能听到有人讨论它们。那结节到底是什么呢？结节并不是特指的某一类疾病，而是指我们通过B超、CT、X光或者MRI等影像学检查方法发现的、比周围组织密度更高 ...

Background and Aim: Intraductal papillary mucinous tumor (IPMT) of the pancreas can be divided into three clinically distinct subtypes: main duct type, branch duct type and mixed type. Although it ...

Mucinous Carcinoma and Papillary Carcinoma) with an F1-score of 94%. The F1-score is a balanced metric used for evaluating models on imbalanced datasets, such as the present one. An F1-score of 100% ...

Two patients with adenocarcinoma, Grade I, showed invasion of the pedicle, though only 1 had evidence of metastasis to the regional lymph nodes; this tumor was a papillary adenoma. However ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.